. In both cases, mutations in the liver, kidney and lung were predominantly base substitutions, among which G:C->A:T transitions were the most frequent In contrast, a high incidence of short deletions (2-23 bp) was only found in the liver of treated mice. The deletions often occurred at direct repeat sequences. Single-base deletion incidence was also higher in the liver than in the kidney and lung. These results imply that accumulation of DNA lesions or their repair in liver is different from other organs. Spontaneous and induced base substitutions and deletions appeared to be randomly distributed in the lac I gene and an apparent hotspot was not observed, except for a 4 bp deletion of a (TGGC) 3 sequence at positions 621-632. The present data demonstrate, for the first time, that DMN induces short deletions especially in the liver, although the mechanism involved needs further investigation.
Introduction
Dimethylnitrosamine (DMN) has been detected in foods, • tobacco smoke and industrial products (Sankaranarayanan, 1981) . It produces tumors in several strains of mice, predominantly in the liver, kidney and lung (International Agency for Research on Cancer, 1978) . The mutational specificity of DMN has been studied in bacterial, mammalian and transgenic mouse systems (Horsfall et al., 1989; Devereux et al., 1991; Jiao et al., 1993; Mirsalis et al., 1993) . The general conclusion is that the DNA methylation responsible for mutation induction occurs primarily at the oxygen of carbon atom 6 in guanine (Beranek, 1990) . C^-mediylguanine (C^-meG) can pair with thymine and, during replication, this leads to G:C-»A:T transitions (Loveless, 1969) .
In a previous study, we demonstrated the organ specificity of DMN-induced mutation in Big Blue 0 mice (C57BL/6) between target organs (liver, ] un g and kidney) and nontarget organs (bone marrow, urinary bladder and testis) for carcinogenesis; daily treatments for 5 days with DMN increased the mutant frequencies fMF) of the lad transgene in the liver (6.2 X control), kidney (2.4 X control) and lung (2. IX control) (Suzuki et al., 1996) . In this study, we further investigated the mutational spectrum of DMN in the lacl transgene of Big Blue® mice (C57BL/6) with 5 daily treatments and a single treatment and found that DMN induced short deletions (2-23 bp) in the liver, but not in the kidney or lung.
Materials and methods

Mouse strain and DMN treatment
Male Big Blue* C57BL/6 transgenic mice 7 weeks of age were purchased from Stratagene (La Jolla, CA). After 1 week acclimation, randomized groups of 10 mice were treated with daily i.p. injections of 1 mg/kg DMN (Wako Pure Chemical, Osaka, Japan) for 5 days or 10 mg/kg DMN once, at a volume of 10 ml/kg. Olive oil was used for the vehicle and was injected into control mice at a volume of 10 ml/kg (Suzuki et al., 1996) . Three mice per group were used for the mutation assay and also DNA sequence analyses.
Genomic DNA isolation and mutation assay
After an expression period (1 week for 5 daily treatments, 2 weeks for single treatments), mice were killed for the lacl mutation assay. Genomic DNA isolation and the assay were done according to the Stratagene Big Blue 9 Instruction Manual (08/1992) and Rogers et al. (1995) and mutation frequency was analyzed as described by Suzuki et al. (1996) .
Sequence analysis of lacl mutants
Three to six mutants/mouse in the control group and 12-31 mutants/mouse in the DMN-treated group were analyzed. Mutant plaques were confirmed and purified by re-infection into Escherichia colt strain SCS-8 and replating on an agar plate containing X-gal. The lacl and flanking regions were directly amplified by PCR with the phage suspension and the products were purified on MicroSpin™ S-400 Columns (Pharmacia Biotech, Tokyo, Japan). Aliquots of 20 pmol each of the two oligonucleotide primers specific for the 5'-and 3'-regions of the lacl gene were used. They were complementary to positions -50 to -31 (5'-GACACCATCGAATGGTGCAA-3') and positions 1197 to 1178 (5'-TTCCACACAACATACGAGCC-3'). The PCR was performed with initial denaturation at 95°C for 5 min, followed by 30 cycles of 95°C for 20 s, 53°C for 30 s and 72°C for 40 s, and then 72°C for 10 min for the elongation reaction.
Thermal cycle sequencing of the lacl gene was performed with an ALFred DNA Sequencer with primer labeled with fluorescein (Pharmacia Biotech, Tokyo, Japan) or with an ABI PRISM™ 310 Genetic Analyzer by dideoxy chain termination, labeling with fluorescein (PE Applied Biosystems, Chiba, Japan). The DNA sequences of 165 mutants isolated from the livers of control mice and liver, kidney and lung of DMN-treated mice were analyzed.
Results
As reported in a previous paper (Suzuki et al., 1996) , DMN increased the MF in liver, kidney and lung to ~2-8 times die control values (Table I ). In die liver of control mice, 22 spontaneous mutants, consisting of 10 and 12 obtained from die single and five daily vehicle treatments, respectively, were sequenced. The most frequent mutations were base substitutions (77%), followed by single base deletions (18%). Multiple-base deletion incidence was low (5%).
In the livers of mice treated singly and widi five daily doses of DMN, the most frequent mutations were base substitutions (57 and 43%, respectively), followed by multiple-base deletions (28 and 36%), then single base deletions (12 and 21%) and, finally, single base insertions (3 and 0%). The frequencies of multiple-base deletions were significantly higher than in die
••To whom correspondence should be addressed. Tel: +81 3 3700 9872; Fax: +81 3 37C0 2348; Email: hayashi@nihs.go.jp X.Wang et aL (100) 35 (57) 15 (25) 2 (3) 4 (7) 1 (20) 10 (16) 3 (5) 17 (28) 7 (12) (100) 17 (89) 15 (79) 
20 (100) 18 (90) 11 (55) 2 (10) 2 (10) 2 (10) 
22 (100) 17 (77) 10 (45) 2 (9) 1 (5) 1 (5) 3 (13) 
"Containing 10 and 12 spontaneous mutants from control mice with single and five daily treatments, using olive oil for the vehicle. MF in this table was five daily treatments; MF for a single treatment was 7 4X 10"
6
. MFs in kidney and lung of the control mice were 19 OX 10" 6 and 13.5X 10"" 6 , respectively (Suzuki et al, 1996) . b One mutant had two mutations, a G:C -> C.G transversion and a short deletion (6 bp). This mutation was AA -» T at positions 712-713. control group (f = 0.02), while the frequencies of single-base deletions were comparable (Table I) . In kidney and lung of DMN-treated mice, base substitutions predominated to an even greater degree (89 and 90%), but multiple-base deletions were significantly lower (5 and 0%) than in liver. Single-base deletions in kidney and lung were also lower than in liver of both DMN-treated and control mice.
Base substitutions
The largest class of base substitutions in kidney and lung of mice receiving five daily treatments comprised G:C->A:T transitions (88%, 15/17, and 61%, 11/18, respectively) ( Table  I) . G:C-*A:T transitions in the liver of mice treated five times were comparable (74%, 14/19), but this base substitution was significantly lower (43%, 15/35) after a single DMN treatment. In the liver of singly treated mice, in contrast, G:C->T:A transversions were higher (29%, 10/35) than in all three organs of the mice given five doses (~5%). In the control, 59% (10/ 17) of base substitutions were G:C-»A:T transitions and 18% (3/17) were G:C->T:A transversions.
The type and location of base substitutions in the liver of singly treated, five times treated and control mice are shown in Table II . No apparent hotspots were observed and the base substitutions appeared to be distributed at random (44 sites among positions 42-1011). In kidney and lung, 47 and 50% of the base substitutions were observed in positions other than those in liver (data not shown). One mutant had two mutations, a G:C->C:G transversion and a short deletion (6 bp), and one mutant showed G:C-»A:T transitions at two adjacent guanine residues (Tables I and II ). All base substitutions analyzed resulted in the formation of a missense or stop codon. Table III summarizes the sequence data for multiple-base deletions detected in the liver of DMN-treated mice. All of them were short deletions of 2-23 bp, except for one 850 bp (positions 8-858) deletion. They seemed to be randomly distributed, except for a 4 bp deletion at positions 621-632, 626 which occurred 10 times. Both terminal regions of deleted sequences often showed the same sequence patterns, i.e. they were direct repeat sequences, and contained guanine residues at the 5'-end (Table ITT) .
Multiple-base deletions
Single-base deletions and insertions
The position and surrounding sequences of single-base deletions are shown in Table IV . Ninety per cent (18/20) of such deletions occurred in a G:C base pair and -50% occurred at a repetitive 2 or 3 base string.
Only three single-base insertions were observed in DMNtreated mice (Table I) . One was insertion of a cytosine between the repeating cytosines at positions 178 and 179, one a guanine between the thymine and cytosine at positions 658 and 659 and one an adenine between the repeating adenines at positions 378 and 379. Discussion Among 22 mutations in the control mice, base substitutions (77%) were predominant. The largest class of base substitutions comprised G:C->A:T transitions (59%) and most (60%) of them were located at CpG sites, which suggests a possible involvement of deamination of 5-methylcytosine. The spontaneous mutation spectrum of the lad gene obtained in this study was similar to that of other lad transgenic mouse assays: C57BL/6, liver and bone marrow (Ushijima et al., 1994) ; B6C3F1, T cell (Walker et al, 1996) ; C57BL/6, liver (Dycaico et al., 1996); C57BIV6 and B6C3F1 combined, liver (De Boer et al., 1996) .
The sequence analyses of spontaneous mutations in lad of E.coli indicated that -67% of the mutations occurred at the hotspot sites involving positions 621-632, where a triple tandem repeat sequence, TGGC, resides (Schaaper et al., 1986) ; these involved either insertion of one TGGC sequence (54% of total mutations) or deletion of one TGGC sequence (13%). The base substitution incidence was only 11%. The spontaneous mutation spectrum in lad of the Big Blue® mice Target   GTA  GTC  CAG  TCC  TCC  AAC  AAA  ATT  GTG  GCG  GAA  GAC  GGC  GGC  GGC  GAC  TCC  ATG  GAT  CTG  GGG  AAA   GTC  GTT  CTT   TAT  CTG  GGC  AAA  CTG  CCC  AAA   AAA  TCA   TAT  GCG  GCG  CCC  CTG  GCG  CAG  GTG  CTG  GGC   TAT  TAT  CTG  CTG  AGC   sequence*   ACG   gCA   ACC  CGC  CGC  CAG  GTG  CCC  GCA  GGC  CGA  GGT  TGG  TGG  TGG  TGG  GGT  CAA  CAG  GGC  CAA  ACC   TCT  TCC  CTC   CAG  ATC  TGG   TAX   GTT  GTC  AGA   TAT  ACC   CAG  GCG  GAG  AAC  GCG  GGC  TCG  GAA  GGC  GCA   GCC  CAG  GCG  GCT  TCA   TTA  GAG  GTT  GTG  GTG  GCC  GAA  AAC obtained in this study, however, was remarkably different from that in E.coli. Neither insertion nor deletion of TGGC at positions 621-632 was found (TGGC deletions at the same position were found in DMN-treated mice) and the base substitution incidence was extremely high (77%). Such differences may suggest that the mutations in the lad gene of Big Blue mice were fixed within mice rather than in E.coli during selection of mutant plaques in vitro.
DMN-induced mutations in the lad gene of E.coli are predominantly G:C->A:T transitions (80-90%) (Horsfall et al., 1989; Jiao et al., 1993) , as are those of the lad transgene in livers of DMN-treated Big Blue G B6C3F1 mice (80%) (Mirsalis et al, 1993) . In the present study of DMN-treated Big Blue® C57BL/6 mice, however, the G:C-»A:T transition incidence in liver was only 25-32% and short deletions (2-23 bp) were observed in liver at almost the same incidence (28-36%) as that X.Wang et at Sequence change"
"Target and altered residues are underlined. Repeat sequences are indicated by bold italic letters. Sequences are shown in the 5'-»3' direction. b This mutant contained one base substitution at position 623 Table IV . Single-base deletions in liver of DMN-treated and control mice Deleted base 
"Target and altered residues are underlined Sequences are shown in the 5'->3' direction.
of G:C-»A:T transitions. Short deletions were also observed in the kidney of DMN-treated mice and the liver of control mice, but the incidence was low (5%). None were detected in the lung. The induction of deletions in the liver of DMN-treated mice accounted for a significant increase in lad MF. Similar analysis of the XcII gene from same samples also indicated that short deletions (5-9 bp) were found in the liver of treated mice, but not in the liver of control mice (unpublished data).
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These results suggest that the liver is the target organ for DMN-induced short deletions in Big Blue® C57B176 mice.
The difference between our study and the study by Mirsalis et al. (1993) is most likely due to different mouse strains (C57BL/6 versus B6C3F1). Short deletions (<20 bp), implicated in human genetic disease, involve repeated sequences, as did those in the present study (Krawczak and Cooper, 1991) . Sequence analysis of deletion mutations has frequently revealed short repeat sequences at the deletion site (Farabaugh et al, 1978; Efstratiadis et al, 1980; Albertini et al, 1982; Nalbantoglu et al, 1986; Roth and Wilson, 1986; Ashmam and Davidson, 1987; Brunier et al, 1989; Canning and Dryja, 1989; Schaaper et al, 1990; Monnet et al, 1992; Thacker et al, 1992; Leach et al, 1993; Morris and Thacker, 1993; Strand et al, 1993) . Two mechanisms of deletion mutagenesis at short repetitive sequences have been proposed: slippage-misalignment (Efstratiadis et al, 1980; Roth and Wilson, 1986; Schaaper et al, 1990; Kimura et al, 1994) and end joining or non-homologous recombination (Roth and Wilson, 1986; Thacker et al, 1992) . Slippage-misalignment is a ubiquitous mechanism of mammalian mutagenesis (Kimura et al, 1994) .
DMN produces a variety of DNA adducts, i.e. NI-, N3-and A^-methyladenine, AG-methylcytosine, Nl-and C^-meG and N3-and C^-methylthymine (Beranek, 1990) . Mispairing of O 6 -meG with thymine is thought to be responsible for G:C->A:T transitions. Deletion formation by DMN is crucial in considering the underlying mechanism. It is conceivable that some of above-mentioned DNA adducts produced in the liver of DMN-treated mice are acting as premutagenic lesions in replication. Both terminal regions of deleted sequences in multiple-base deletions observed in the present study often showed the same sequence patterns, i.e. a direct repeat sequence. This may result in looping out of the deleted sequences by misalignment between two direct repeat sequences. Thus, the deletions that occurred at repeat sequences can be explained by the slippage-misalignment model (Kimura et al, 1994) .
The kidney of DMN-treated mice showed over twice the MF of the control organ. Although the increase was not high, DMN-specific G:C->A:T transitions were induced. An increase in G:C->A:T transitions was less obvious in the lung, but its MF increased to twice that of the control. Single-base deletion incidence was higher in the liver than in the kidney and lung of mice that received five daily injections of DMN. These differences among organs may reflect tissue specificity of DMN-induced mutation that is caused by differences in accumulation of DNA lesions or their repair.
In E.coli, G:C-->A:T transitions was predominantly induced by DMN and occurred at several hotspots, such as positions 75, 84, 90 and 201 (Jiao et al, 1993) . Further, site specificity of G:C->A:T transitions was observed at 5'-PuG-3' (>80%) rather than at 5'-PyG-3' (Jiao et al, 1996) . In the present study, however, G:C-»A:T transitions induced by DMN appeared to be randomly distributed in the lacl gene and no site specificity could be detected; based on calculations on the data in Table  n , 5'-PuG-3' constituted 38% and 5'-PyG-3' 62%. Similar results were observed in the lacZ and kcll genes of transgenic mice treated with ethylnitrosourea and DMN, respectively (Suzuki et al, 1997; unpublished data) . The lacl gene is not expressed in the tissues of mouse, therefore, the transcriptionrepair coupling apparent in E.coli Brash, 1992, 1995) , did not operate. This might explain why hotspots and site specificity for G:C-»A:T transitions were not found in the present study.
